Skip to main content
SpringerLink
Log in

Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?

  • Viewpoint
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hostetter TH and Ibrahim HN (2003) Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol 14: 2395–2401

    Article  PubMed  Google Scholar 

  2. Bomback AS and Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3: 486–492

    Article  CAS  PubMed  Google Scholar 

  3. Bomback AS et al. (2008) Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kidney Dis 51: 199–211

    Article  PubMed  Google Scholar 

  4. Monrad SU et al. (2008) The role of aldosterone blockade in murine lupus nephritis. Arthritis Res Ther 10: R5

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bochud M et al. (2006) Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 48: 239–245

    Article  CAS  PubMed  Google Scholar 

  6. de Paula RB et al. (2004) Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43: 41–47

    Article  CAS  PubMed  Google Scholar 

  7. Nagase M et al. (2006) Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 17: 3438–3446

    Article  CAS  PubMed  Google Scholar 

  8. Pérez-Rojas JM et al. (2005) Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 289: F1020–F1030

    Article  PubMed  Google Scholar 

  9. Pérez-Rojas J et al. (2007) Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Am J Physiol Renal Physiol 292: F131–F139

    Article  PubMed  Google Scholar 

  10. Mejía-Vilet JM et al. (2007) Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293: F78–F86

    Article  PubMed  Google Scholar 

  11. Sato A and Saruta T (2004) Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res 27: 303–310

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AV Kshirsagar is Associate Professor of Medicine and PJ Klemmer is Professor of Medicine in the Department of Medicine, Division of Nephrology and Hypertension, AS Bomback is the Doc J Thurston III Fellow, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.,

    Andrew S Bomback, Abhijit V Kshirsagar & Philip J Klemmer

Authors
  1. Andrew S Bomback
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhijit V Kshirsagar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip J Klemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew S Bomback.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bomback, A., Kshirsagar, A. & Klemmer, P. Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?. Nat Rev Nephrol 5, 74–75 (2009). https://doi.org/10.1038/ncpneph1004

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph1004

  • Springer Nature Limited

This article is cited by

Search

Navigation